Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.08% |
| 2 | Financials | 6.03% |
| 3 | Industrials | 5.01% |
| 4 | Consumer Discretionary | 4.73% |
| 5 | Healthcare | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3476
AngioDynamics
ANGO
$647M
| $2M | ﹤0.01% |
120,271
+32,034
| +36% | +$547K |
|
3477
Vanda Pharmaceuticals
VNDA
$304M
| $2M | ﹤0.01% |
131,600
-658,785
| -83% | -$9.78M |
|
3478
PUT
International Flavors & Fragrances
IFF
$21.4B
| $2M | ﹤0.01% |
13,100
+2,900
| +28% | +$436K |
|
3479
NeoGenomics
NEO
$2.11B
| $2M | ﹤0.01% |
225,454
+15,934
| +8% | +$147K |
|
3480
PUT
WIX.com
WIX
$3.35B
| $2M | ﹤0.01% |
34,700
+11,200
| +48% | +$693K |
|
|
GHL
3481
DELISTED
Greenhill & Co., Inc.
GHL
| $2M | ﹤0.01% |
102,405
+81,650
| +393% | +$1.52M |
|
3482
PUT
Icon
ICLR
$12.9B
| $2M | ﹤0.01% |
17,800
+12,000
| +207% | +$1.38M |
|
3483
CALL
WEC Energy
WEC
$35.9B
| $1.99M | ﹤0.01% |
30,000
+25,100
| +512% | +$1.68M |
|
|
OPB
3484
DELISTED
Opus Bank Common Stock
OPB
| $1.99M | ﹤0.01% |
72,908
-44,363
| -38% | -$1.15M |
|
|
BIVV
3485
DELISTED
Bioverativ Inc. Common Stock
BIVV
| $1.99M | ﹤0.01% |
36,907
-88,272
| -71% | -$4.83M |
|
|
RDFN
3486
PUT
DELISTED
Redfin
RDFN
| $1.99M | ﹤0.01% |
63,400
+43,800
| +223% | +$1.06M |
|
3487
Interface
TILE
$2.24B
| $1.99M | ﹤0.01% |
78,964
+42,063
| +114% | +$986K |
|
3488
CALL
Invesco DB Commodity Index Tracking Fund
DBC
$1.71B
| $1.99M | ﹤0.01% |
119,500
+82,900
| +227% | +$1.32M |
|
|
WRK
3489
PUT
DELISTED
WestRock Company
WRK
| $1.99M | ﹤0.01% |
31,400
+500
| +2% | +$30.4K |
|
|
JO
3490
DELISTED
iPath Bloomberg Coffee Subindex Total Return ETN due June 24, 2038
JO
| $1.98M | ﹤0.01% |
126,364
+114,711
| +984% | +$1.83M |
|
3491
Xcel Energy
XEL
$49.3B
| $1.98M | ﹤0.01% |
41,200
-49,732
| -55% | -$2.47M |
|
|
CEO
3492
CALL
DELISTED
CNOOC Limited
CEO
| $1.98M | ﹤0.01% |
13,800
-100
| -0.7% | -$13.6K |
|
3493
ProShares UltraShort Yen
YCS
$30M
| $1.98M | ﹤0.01% |
105,580
+50,936
| +93% | +$954K |
|
|
QVCGA
3494
PUT
DELISTED
QVC Group Inc Series A
QVCGA
| $1.98M | ﹤0.01% |
1,669
+1,232
| +282% | +$1.43M |
|
|
WUBA
3495
DELISTED
58.com Inc
WUBA
| $1.98M | ﹤0.01% |
+27,620
| New | +$1.91M |
|
3496
CALL
Franklin Resources
BEN
$17.2B
| $1.98M | ﹤0.01% |
45,600
-23,800
| -34% | -$1.03M |
|
3497
CALL
GoPro
GPRO
$117M
| $1.98M | ﹤0.01% |
261,000
+3,700
| +1% | +$32.8K |
|
|
HTT
3498
High Templar Tech Ltd
HTT
$391M
| $1.98M | ﹤0.01% |
+157,549
| New | +$3.04M |
|
3499
Sanofi
SNY
$105B
| $1.98M | ﹤0.01% |
+45,957
| New | +$2.12M |
|
3500
EXL Service
EXLS
$5.36B
| $1.97M | ﹤0.01% |
163,435
+59,560
| +57% | +$727K |
|
Similar funds
Citadel Advisors's Q4 2017 Portfolio in Review
As of Q4 2017, Citadel Advisors held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Citadel Advisors deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Citadel Advisors's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Citadel Advisors's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Citadel Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Citadel Advisors's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Citadel Advisors opened 1,440 new positions and closed 988 in Q4 2017.
- Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.